Phase 4 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand and agree to take part in the trial and have signed a consent form
- People who have one or more lung nodules of a specific size (6–15 mm) that have been found on a CT chest scan and have not yet been clearly identified as cancerous or non-cancerous
- People who have already had a routine PET/CT scan using a substance called 18F-FDG (a type of imaging scan)
- People who are already scheduled to have a biopsy or surgical removal of their lung nodule(s)
Who may not be able to join:
- People who experience severe anxiety or fear in enclosed spaces (claustrophobia)
- People who are pregnant or currently breastfeeding
- People who have received systemic anti-cancer treatment (such as chemotherapy) within the last 2 weeks before their PET scan
- People who have had radiation therapy directed at the lung nodule(s) being studied
- People who have diabetes that is not well controlled
- People who have any other medical condition that could interfere with taking part in the trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adrienne H Brouwers, MD PhD, Nuclear Medicine physician
Phone: +31503613093
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Description of optimized (in terms of e.g. activity dose needed for injection, time of scan duration, post-processing filtering) static whole-body acquisition and reconstruction protocol by performing semi-quantitative (SUV) analysis.; Description of optimized (in terms of e.g. activity dose needed for injection, time of scan duration) dynamic whole-body acquisition and reconstruction protocol by performing kinetic modelling (Patlak, Ki) analysis.; Description of optimized breath-hold acquisition and reconstruction protocol by performing semi-quantitative (SUV) analysis and compare with outcom...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.